Search company, investor...

Aperta Biosciences

Founded Year



Debt | Alive

Total Raised


Last Raised

$180K | 5 yrs ago

About Aperta Biosciences

Aperta Biosciences develops safe and effective therapeutics for chronic inflammatory ophthalmic diseases.

Headquarters Location

20 S. Sarah Street

Saint Louis, Missouri, 63108,

United States

Missing: Aperta Biosciences's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Aperta Biosciences's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Aperta Biosciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Aperta Biosciences is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Aperta Biosciences Patents

Aperta Biosciences has filed 3 patents.

The 3 most popular patent topics include:

  • Diseases of the eye and adnexa
  • Disorders of sclera and cornea
  • Inflammations
patents chart

Application Date

Grant Date


Related Topics




Trifluoromethyl compounds, Diseases of the eye and adnexa, Inflammations, Disorders of sclera and cornea, Phenols


Application Date


Grant Date



Related Topics

Trifluoromethyl compounds, Diseases of the eye and adnexa, Inflammations, Disorders of sclera and cornea, Phenols



Aperta Biosciences Frequently Asked Questions (FAQ)

  • When was Aperta Biosciences founded?

    Aperta Biosciences was founded in 2017.

  • Where is Aperta Biosciences's headquarters?

    Aperta Biosciences's headquarters is located at 20 S. Sarah Street, Saint Louis.

  • What is Aperta Biosciences's latest funding round?

    Aperta Biosciences's latest funding round is Debt.

  • How much did Aperta Biosciences raise?

    Aperta Biosciences raised a total of $180K.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.